Quantbot Technologies LP Igm Biosciences, Inc. Transaction History

Quantbot Technologies LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$8.68 - $17.36 $6,944 - $13,888	800 New	800 $7,000
Q3 2023 Nov 07, 2023	BUY	$6.66 - $10.64 $11,988 - $19,152	1,800 New	1,800 $15,000
Q3 2022 Nov 07, 2022	BUY	$15.42 - $27.01 $55,512 - $97,236	3,600 New	3,600 $81,000
Q2 2022 Aug 09, 2022	SELL	$13.27 - $25.5 $6,104 - $11,730	-460 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$13.42 - $29.73 $845 - $1,872	-63 Reduced 12.05%	460 $12,000
Q4 2021 Feb 11, 2022	BUY	$27.59 - $66.39 $11,670 - $28,082	423 Added 423.0%	523 $15,000
Q3 2021 Nov 09, 2021	SELL	$65.76 - $90.65 $13,152 - $18,130	-200 Reduced 66.67%	100 $6,000
Q2 2021 Aug 12, 2021	BUY	$57.98 - $96.6 $17,394 - $28,980	300 New	300 $24,000
Q1 2021 May 14, 2021	SELL	$71.56 - $121.23 $7,156 - $12,123	-100 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$47.41 - $115.03 $4,741 - $11,503	100 New	100 $8,000

21.4M

39.5K

16.5K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $500M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.